SUPERLUMINAL MEDICINES, INC.
Profile
Company Names
SUPERLUMINAL MEDICINES, INC.
Addresses
15 NECCO ST., LILLY GATEWAY LABS, 4TH FLOOR, BOSTON, MA 02110
303 WYMAN ST., SUITE 300, WALTHAM, MA 02451
200 BERKELEY ST., 18TH FLOOR, BOSTON, MA 02116
Phone Numbers
(301) 525-8752
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2023
State Incorporated:
DELAWARE
Total Amount Raised:
$50,720,767.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-08-14
$5,000,000.00
$5,000,000.00
$0.00
Debt
2
2024-08-21
$20,041,660.00
$119,999,984.00
$99,958,324.00
Equity
1
2023-03-03
$25,679,107.00
$25,679,107.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANDREW
LEVIN
DIRECTOR
IMMUNETICS, INC.
| ARVINAS HOLDING COMPANY, LLC
| SYNTHORX, INC.
| CLEANBREAK, INC.
| CLEAR CREEK BIO, INC.
| IMBRIA PHARMACEUTICALS, INC.
| ELIEM THERAPEUTICS, INC.
| ATHENEN THERAPEUTICS, INC.
| ARCUATE THERAPEUTICS, INC.
| AEROVATE THERAPEUTICS, INC.
| SANTI THERAPEUTICS, INC.
| CYTEK BIOSCIENCES, INC.
| METAGENOMI TECHNOLOGIES, LLC
| LUSARIS THERAPEUTICS, INC.
| SUPERLUMINAL MEDICINES, INC.
| NAVIGATOR MEDICINES, INC.
| AKTIS ONCOLOGY, INC.
| PAHR THERAPEUTICS, INC.
| LONESTAR MEDICINES, INC.
| SOLSTICE ONCOLOGY, INC.
| SLATE MEDICINES, INC.
| CLIMB BIO, INC.
DYLAN
MORRIS
DIRECTOR
DIAMANTIS
XYLAS
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
